Circulation. 2009;119:1977-2016
Published online before print March 26, 2009,
doi: 10.1161/CIRCULATIONAHA.109.192064
(Circulation. 2009;119:1977-2016.)
© 2009 American Heart Association, Inc.
ACCF/AHA Practice Guideline: Focused Update |
2009 Focused Update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults
A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation
2009 WRITING GROUP TO REVIEW NEW EVIDENCE AND UPDATE THE 2005 GUIDELINE FOR THE MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE WRITING ON BEHALF OF THE 2005 HEART FAILURE WRITING COMMITTEE;
Mariell Jessup, MD, FACC, FAHA, Chair*;
William T. Abraham, MD, FACC, FAHA
;
Donald E. Casey, MD, MPH, MBA
;
Arthur M. Feldman, MD, PhD, FACC, FAHA
;
Gary S. Francis, MD, FACC, FAHA
;
Theodore G. Ganiats, MD||;
Marvin A. Konstam, MD, FACC¶;
Donna M. Mancini, MD#;
Peter S. Rahko, MD, FACC, FAHA
;
Marc A. Silver, MD, FACC, FAHA**;
Lynne Warner Stevenson, MD, FACC, FAHA
;
Clyde W. Yancy, MD, FACC, FAHA
Key Words: ACCF/AHA practice guideline focused update heart failure hospitalized patient refractory end-stage heart failure
An extract of the first 250 words of the full text is provided, because this article has no abstract.
|
 |
Introduction
|
|---|
- Preamble...1978
- 1. Introduction...1980
- 1.1. Evidence Review...1980
- 1.2. Organization of Committee and Relationships With Industry...1980
- 1.3. Review and Approval...1980
- 1.4. Stages of Heart Failure: Information From the 2005 Guideline...1981
- 3. Initial and Serial Clinical Assessment of Patients Presenting With Heart Failure...1981
- 3.1. Initial Evaluation of Patients...1981
- 3.1.1. Identification of Patients...1981
- 3.1.2. Identification of a Structural and Functional Abnormality...1984
- 3.1.3.2. Laboratory Testing...1985
- 3.2.3. Laboratory Assessment...1985
- 3.2.4. Assessment of Prognosis...1986
- 4. Therapy...1987
- 4.3.1. Patients With Reduced Left Ventricular Ejection Fraction...1987
- 4.3.1.1. General Measures...1987
- 4.3.1.2.5. Ventricular Arrhythmias and Prevention of Sudden Death...1990
- 4.3.1.3.3. Hydralazine and Isosorbide Dinitrate...1993
- 4.3.1.3.4. Cardiac Resynchronization Therapy...1993
- 4.3.1.5.2. Intermittent Intravenous Positive Inotropic Therapy...1994
- 4.4. Patients With Refractory End-Stage Heart Failure (Stage D)...1994
- 4.4.3. Intravenous Peripheral Vasodilators and Positive Inotropic Agents...1996
- 4.5. The Hospitalized Patient (New Section)...1996
- 4.5.1. Diagnostic Strategies...1998
- 4.5.2. Treatment in the Hospital...1999
- 4.5.2.1. Diuretics: The Patient With Volume Overload...1999
- 4.5.2.2. Vasodilators...2000
- 4.5.2.3. Inotropes...2000
- 4.5.2.4. Other Considerations...2001
- 4.5.3. The Hospital Discharge...2001
- 5. Treatment of Special Populations...2002
- 6. Patients With Heart Failure Who Have Concomitant Disorders...2002
- 6.1.3. Supraventricular Arrhythmias...2002
- References...2004
- Appendix 1...2012
- Appendix 2...2013
 |
Preamble
|
|---|
A primary challenge in the development of clinical practice
guidelines is keeping pace with the stream of new data on which
recommendations are based. In an effort to respond more quickly
to new evidence, the American College of Cardiology Foundation/American
Heart Association (ACCF/AHA) Task Force on Practice Guidelines
has created a "focused update" process to revise the existing
guideline recommendations that are affected by the evolving
data or opinion. Prior to the initiation of this focused
. . . [Full Text of this Article]
Related Internet Resources:
- 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
- Supporting Materials From the American Heart Association
This article has been cited by other articles:

|
 |

|
 |
 
J. C. Schultz, A. A. Hilliard, L. T. Cooper Jr, and C. S. Rihal
Diagnosis and Treatment of Viral Myocarditis
Mayo Clin. Proc.,
November 1, 2009;
84(11):
1001 - 1009.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Daubert, C. Leclercq, and P. Mabo
Cardiac resynchronization therapy in combination with implantable cardioverter-defibrillator
Europace,
November 1, 2009;
11(suppl_5):
v87 - v92.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Jessup
MADIT-CRT -- Breathtaking or Time to Catch Our Breath?
N. Engl. J. Med.,
October 1, 2009;
361(14):
1394 - 1396.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M Schou, U Alehagen, J P Goetze, F Gustafsson, and U Dahlstrom
Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals
Heart,
September 15, 2009;
95(18):
1514 - 1519.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. T. Shin and G. W. Dec
Ultrafiltration Should Not Replace Diuretics for the Initial Treatment of Acute Decompensated Heart Failure
Circ Heart Fail,
September 1, 2009;
2(5):
505 - 511.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Fonarow and E. D. Peterson
Heart Failure Performance Measures and Outcomes: Real or Illusory Gains
JAMA,
August 19, 2009;
302(7):
792 - 794.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. Diamond and S. Kaul
Bayesian Classification of Clinical Practice Guidelines
Arch Intern Med,
August 10, 2009;
169(15):
1431 - 1435.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. H. W. Tang
Natriuretic Peptide Measurements in Managing Heart Failure: In Theory and in Practice
Circ Heart Fail,
July 1, 2009;
2(4):
380 - 381.
[Full Text]
[PDF]
|
 |
|